About this trial
This study will evaluate whether Xuanwu-NeuroAid 2.0, a large language model for emergency neurology, can improve 30-day diagnostic quality in adults with acute neurological symptoms. Physicians will be randomly assigned to AI-assisted care or usual care. In the AI-assisted group, the model will provide diagnostic and management suggestions, while physicians will make all final clinical decisions. The usual-care group will receive standard emergency neurology care without large language model assistance.
Eligibility criteria
Qualifiers
Age ≥18 years;
Presentation to the emergency neurology service with acute neurological symptoms;
Written informed consent provided by the patient or a legally authorized representative.
Disqualifiers
Presentation primarily for trauma;
Pregnancy;
Requiring immediate life-saving interventions;
Estimated life expectancy of less than 30 days;
Trial design
Treatments tested in this trial
- Xuanwu-NeuroAid 2.0
Treatment groups
Locations
3Sponsors and collaborators
Capital Medical University
Lead sponsor